Text Size

Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication

Uusitalo H., Chen E., Pfeiffer N., Brignole-Baudouin F., Kaarniranta K., Leino M., Puska P., Palmgren E., Hamacher T., Hofmann G., Petzold G., Richter U., Riedel T., Winter M., Ropo A.


  • 2010
  • Acta Ophthalmologica
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    University of Tampere, Tampere University Hospital, Tampere, Finland; St Erik Eye Hospital, Stockholm, Sweden; Augenklinik der Joh.-Gutenberg- Universität Mainz, Mainz, Germany; Department of Toxicology, University Paris Descartes, University Paris 6, Paris, France; University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland; Kuopion Näkökeskus, Kuopio, Finland; Helsingin Lääkärikeskus, Helsinki, Finland; Nyköpings Lasarett, Nyköping, Sweden; Praxis Starnberg, Starnberg, Germany; Praxis Schweinfurt, Schweinfurt, Germany; Praxis Kulmbach, Kulmbach, Germany; Praxis Regensburg, Regensburg, Germany; Praxis Dresden, Dresden, Germany; Praxis Bremen, Bremen, Germany; Santen Oy, Tampere, Finland

Related Publications

Benefit of omidenepag isopropyl ophthalmic solution in treatment persistence in Japanese patients with glaucoma

Kashiwagi K., Nakano T., Nakazawa T., Fuwa M., Otsuka N., Shii D., Miyahara R.


Posterior Ciliary Artery Contraction by Bradykinin Receptor Subtypes and Implications for Retinal Blood Flow Dysfunction

Sharif NA, Ohia SE, Kulkarni-Chitnis M, Okolie A, Chaudhry SD, Njie-Mbye YF


Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A 3-Year Prospective Study

Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022